Trachea

Hopewell Therapeutics to Present Data Highlighting Novel Tissue Targeting Lipid Nanoparticles at the American Society of Gene and Cell Therapy 27th Annual Meeting

Retrieved on: 
Tuesday, May 7, 2024

Hopewell has advanced product candidates that combine tissue-targeting LNPs with proprietary mRNA encoding for therapeutic proteins to treat rare and common diseases.

Key Points: 
  • Hopewell has advanced product candidates that combine tissue-targeting LNPs with proprietary mRNA encoding for therapeutic proteins to treat rare and common diseases.
  • These immune targeting LNPs have been successfully deployed in preclinical cancer vaccine and infectious disease vaccine models.
  • "This is an exciting time for Hopewell," shared Louis Brenner, M.D., Hopewell's President and CEO.
  • Our team is presenting data this week that showcase the progress of our ttLNPs and potential therapeutic applications that could be pursued for patient benefit."

Lucem Health Launches Reveal for Lung Cancer, A New AI-Driven Solution to Accelerate Lung Cancer Screening for At-Risk Patients

Retrieved on: 
Thursday, May 2, 2024

DAVIDSON, N.C., May 2, 2024 /PRNewswire/ -- Lucem Health™, a leader in AI-driven early disease detection solutions, announced today the introduction of Reveal for Lung Cancer. This innovative new solution aims to help healthcare organizations improve the identification and engagement of patients at a higher statistical risk for certain respiratory illnesses, including cancers of the lung or trachea, facilitating earlier diagnosis and treatment.

Key Points: 
  • "Reveal for Lung Cancer provides an effective new solution for addressing the deadliest cancer worldwide," Sean Cassidy.
  • Lung cancer remains the leading cause of cancer death in the United States and the third most common cancer diagnosis.
  • By using Reveal for Lung Cancer for two years, a provider organization can expect to identify about 60% more patients with early-stage lung cancer.
  • "Reveal for Lung Cancer provides an effective new solution for addressing the deadliest cancer worldwide," says Sean Cassidy, CEO of Lucem Health.

Survivor of Grizzly Bear Attack in Big Sky, Montana Shares Story

Retrieved on: 
Wednesday, March 6, 2024

BIG SKY, Mont., March 6, 2024 /PRNewswire/ -- Outlaw Partners and Hey Bear, in conjunction with Explore Big Sky's Hoary Marmot podcast, recently shared an exclusive interview with grizzly bear attack survivor, Rudy Noorlander, a 61-year-old Navy veteran and owner of Alpine Adventures, a snowmobile and ATV rental company in Big Sky, Montana. On September 8, 2023, Noorlander was attacked by a grizzly bear when helping two experienced hunters who rented side-by-sides from his company track down a mule deer they shot in the area. All three were carrying bear spray and guns. (Watch grizzly attack survivor interview here).

Key Points: 
  • BIG SKY, Mont., March 6, 2024 /PRNewswire/ -- Outlaw Partners and Hey Bear, in conjunction with Explore Big Sky's Hoary Marmot podcast , recently shared an exclusive interview with grizzly bear attack survivor, Rudy Noorlander, a 61-year-old Navy veteran and owner of Alpine Adventures, a snowmobile and ATV rental company in Big Sky, Montana.
  • ( Watch grizzly attack survivor interview here ).
  • We want the information we provide to be a tool in learning how to be bear aware and staying safe in bear country."
  • To find out more about bear awareness and how to be more prepared for bear encounters while exploring in bear country, visit www.heybear.com .

Kaneka Acquires Japan Medical Device Technology

Retrieved on: 
Wednesday, December 6, 2023

Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka)(TOKYO:4118) has acquired all shares of Japan Medical Device Technology Co., Ltd. (Headquarters: Kamimashiki-gun, Kumamoto; President: Shuzo Yamashita) (hereinafter JMDT), a developer and manufacturer of medical devices, on November 30, 2023, and made it a wholly owned subsidiary.

Key Points: 
  • Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka)(TOKYO:4118) has acquired all shares of Japan Medical Device Technology Co., Ltd. (Headquarters: Kamimashiki-gun, Kumamoto; President: Shuzo Yamashita) (hereinafter JMDT), a developer and manufacturer of medical devices, on November 30, 2023, and made it a wholly owned subsidiary.
  • In particular, stenting*1 for the treatment of coronary artery diseases such as atherosclerosis has a market worth 30 billion yen in Japan, and Kaneka is aiming to expand its business in this area.
  • It is a medical device that widens tubular parts of the human body (blood vessels, trachea, esophagus, duodenum, colon, biliary tract, etc.)
  • [Japan Medical Device Technology Co., Ltd.]

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently

Retrieved on: 
Wednesday, November 29, 2023

Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.

Key Points: 
  • Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.
  • "One of the problems for the elderly is incomplete swallowing, and there is some food residue remaining in the oral cavity.
  • Ensure that the patient is mindful of eating and drinking water, concentrating on eating and swallowing all the food.
  • Anti-choke mugs – help ease swallowing, reducing the chance of choking
    As behavioral changes for swallowing is difficult for both patients and caregivers, the research team then developed an "anti-choke mug" to help patients drink water safely.

"Anti-Choke Mug" - Chula Innovation for Neuro Patients to Drink Water Confidently

Retrieved on: 
Wednesday, November 29, 2023

Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.

Key Points: 
  • Choking in these patients can cause pneumonia, lung infections, sepsis, and eventually death, so it should not be overlooked by patients and caregivers.
  • "One of the problems for the elderly is incomplete swallowing, and there is some food residue remaining in the oral cavity.
  • Ensure that the patient is mindful of eating and drinking water, concentrating on eating and swallowing all the food.
  • Anti-choke mugs – help ease swallowing, reducing the chance of choking
    As behavioral changes for swallowing is difficult for both patients and caregivers, the research team then developed an "anti-choke mug" to help patients drink water safely.

In Celebration of "Orgasm Day" The Cellular Medicine Association Offers a Free Course, The Female Orgasm System

Retrieved on: 
Thursday, July 27, 2023

Music and food are sometimes called "orgasmic" because orgasm is considered to be the ultimate pleasure; but orgasm is not just about pleasure.

Key Points: 
  • Music and food are sometimes called "orgasmic" because orgasm is considered to be the ultimate pleasure; but orgasm is not just about pleasure.
  • Similarly, the Reproductive System and the Orgasm System share components but are not the same."
  • Dr. Runels, the inventor of the O-Shot® procedure , author of multiple research papers and books, and first to use the terminology "Female Orgasm System," is offering an online seven-week course teaching the Female Orgasm System in hopes of narrowing the orgasm gap.
  • The course is sponsored by the Cellular Medicine Association (CMA) .

Desktop Health™ Introduces the PrintRoll™ Rotating Build Platform for the 3D-Bioplotter® — a First-of-its-kind Bioprinting Tool to Develop Tubular Solutions for Vascular, Digestive, Respiratory, and Other Channels

Retrieved on: 
Monday, July 24, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230724680554/en/
    Nicole Black, Ph.D., VP of Biomaterials and Innovation at Desktop Health, examines two tubular medical devices printed on the new 3D-Bioplotter® PrintRoll™ rotating build platform in medical-grade materials.
  • PrintRoll is designed to enable new medical solutions for the body’s thousands of miles of internal channels, such as vascular, digestive, and other systems.
  • 3D-Bioplotter offers eight printheads with the widest range of temperatures in bioprinting — from 2°C to 500°C (35.6°F to 932°F) — enabling complex, multi-material medical parts.
  • As the PrintRoll tool rotates, the printhead moves back and forth depositing material on the surface in the desired design.

VETERINARIANS AND VETERINARY NURSES/TECHNICIANS LEARN HOW TO PERFORM LIFE-SAVING, EMERGENCY MEDICINE AND MASTER OTHER NEW SKILLS AT 22nd NAVC INSTITUTE

Retrieved on: 
Tuesday, May 2, 2023

ORLANDO, Fla., May 2, 2023 /PRNewswire/ -- Emergency and critical care including respiratory emergencies in dogs and stabilizing and treating an exotic animal experiencing trauma are among the areas of veterinary medicine veterinary professionals from around the world will learn and master during five days of hands-on, immersive training at the 22nd NAVC Institute. Hosted by the North American Veterinary Community (NAVC), the event will take place May 21 - 26 at the Caribe Royale in Orlando, Florida. 

Key Points: 
  • At NAVC Institute, veterinary professionals will have the opportunity to perform and master life-saving procedures.
  • In addition to emergency medicine, NAVC Institute provides courses with sessions on performing knee and hip surgery on dogs, dental procedures on rabbits, spaying turtles and perfecting ultrasound techniques.
  • "At NAVC Institute, veterinary professionals will have the opportunity to perform and master life-saving procedures, expanding the depth and breadth of care they can provide to all their patients."
  • For more information on courses and sessions, see the NAVC Institute Program Guide To register, please contact [email protected] .

Bresotec’s BresoDX1 for At-Home Sleep Apnea Testing Receives FDA 510(k) Clearance

Retrieved on: 
Tuesday, January 3, 2023

Bresotec Medical (“Bresotec” or the “Company”), a medical device company that develops, manufactures, and markets non-invasive portable diagnostic devices for accurate at-home diagnosis of sleep apnea, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for BresoDX1, its initial product for at-home sleep apnea testing.

Key Points: 
  • Bresotec Medical (“Bresotec” or the “Company”), a medical device company that develops, manufactures, and markets non-invasive portable diagnostic devices for accurate at-home diagnosis of sleep apnea, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for BresoDX1, its initial product for at-home sleep apnea testing.
  • BresoDX1 is indicated for use to aid in the diagnosis of moderate to severe sleep apnea in adults in an at-home setting.
  • Once data is uploaded to the BresoDX1 software, BresoDX1 offers clinicians a reliable, turnkey diagnostic tool with fully transparent reporting.
  • The company plans to market BresoDX1 through its internal commercial salesforce and will initially target sleep physicians and sleep centers throughout the United States.